The stock closed at ₹1.83 on May 29, 2026, down 0.54% from the previous session, trading near its 52-week low of ₹1.41 and substantially below its 52-week high of ₹2.69. With negative shareholder equity of ₹3.77 crores and a price-to-book ratio of -1.47x, the company's fundamental distress is unmistakable. Trading volumes remain anaemic at 15,991 shares, reflecting diminished investor interest in this struggling entity.
Financial Performance: A Portrait of Operational Failure
The Q4 FY26 results reveal a company in terminal decline. Negative net sales of ₹0.50 crores—an accounting anomaly that suggests returns or adjustments exceeding gross sales—deteriorated 200.00% sequentially from the already minimal ₹0.50 crores in Q3 FY26. Year-on-year comparison shows a 49.49% decline from negative ₹0.99 crores in Q4 FY25, indicating sustained revenue generation failure across multiple quarters.
| Quarter | Net Sales (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | QoQ Growth |
|---|---|---|---|---|
| Mar'26 | -0.50 | -200.00% | -3.56 | +111.90% |
| Dec'25 | 0.50 | N/A | -1.68 | -41.46% |
| Sep'25 | 0.00 | -100.00% | -2.87 | +6.69% |
| Jun'25 | 0.32 | -132.32% | -2.69 | -27.10% |
| Mar'25 | -0.99 | -247.76% | -3.69 | +57.69% |
| Dec'24 | 0.67 | +109.38% | -2.34 | -11.03% |
| Sep'24 | 0.32 | N/A | -2.63 | N/A |
Operating profit before depreciation, interest, and tax (PBDIT) excluding other income stood at negative ₹0.85 crores in Q4 FY26, a dramatic reversal from the positive ₹0.16 crores in Q3 FY26. This operational loss, combined with substantial interest costs of ₹1.71 crores and depreciation of ₹2.39 crores, pushed the profit before tax to negative ₹3.56 crores. The company generated ₹1.39 crores in other income during the quarter, providing temporary relief but insufficient to offset core operational haemorrhaging.
Employee costs remained relatively stable at ₹0.07 crores in Q4 FY26, marginally higher than ₹0.06 crores in Q3 FY26, suggesting minimal workforce retention. The gross profit margin of 234.0% and PAT margin of 712.0% in Q4 FY26—whilst appearing positive on paper—are mathematical artefacts of negative revenue, rendering traditional margin analysis meaningless in this context.
Critical Alert: Negative Equity Position
With shareholder funds at negative ₹3.77 crores as of March 2025 and reserves and surplus at negative ₹96.52 crores, Prag Bosimi Synthetics has completely eroded its equity capital of ₹92.75 crores. The company's book value per share stands at negative ₹2.54, indicating technical insolvency. This represents a fundamental breach of financial viability, raising serious questions about going concern status.
Balance Sheet Deterioration: Debt Burden Amidst Asset Erosion
The balance sheet as of March 2025 reveals a company weighed down by ₹161.02 crores in long-term debt against fixed assets of ₹164.16 crores. With negative shareholder equity of ₹3.77 crores—deteriorating from positive ₹7.42 crores in March 2024—the company's capital structure has collapsed. Current assets of ₹4.74 crores barely exceed current liabilities of ₹0.68 crores, providing minimal liquidity cushion.
The company's debt-to-equity ratio stands at negative 17.25, a metric rendered meaningless by negative equity. More concerning is the sustained inability to generate operating cash flows, with cash flow from operations at negative ₹1.00 crores for FY25. The company reported zero cash balances across all recent periods, highlighting severe liquidity constraints and dependence on external financing for survival.
Profitability Metrics: Comprehensive Failure Across All Parameters
Return on capital employed (ROCE) averaged negative 5.29% over recent periods, with the latest reading at negative 4.18%, indicating the company destroys value on deployed capital. Return on equity (ROE) stands at 0.0% on average, though this metric is distorted by negative book value. The latest ROE is classified as "Negative BV," confirming the absence of any equity base to measure returns against.
Five-year sales growth stands at negative 100.00%, reflecting the complete evaporation of revenue-generating capability from ₹57.00 crores in FY19 to effectively zero in FY24. The company's EBIT-to-interest coverage ratio averages 0.0x, meaning earnings before interest and tax are insufficient to cover interest obligations—a classic hallmark of financial distress. With interest costs of ₹1.71 crores in Q4 FY26 against negligible operational earnings, the debt burden has become unsustainable.
| Metric | Value | Assessment |
|---|---|---|
| ROCE (Average) | -5.29% | Value Destruction |
| ROCE (Latest) | -4.18% | Weak |
| ROE (Average) | 0.0% | Negative Equity Base |
| 5-Year Sales Growth | -100.00% | Revenue Collapse |
| EBIT to Interest | 0.0x | Unsustainable |
| Debt to Equity | -17.25 | Negative Equity |
Peer Comparison: Underperformance in a Struggling Sector
Within the garments and apparels sector, Prag Bosimi Synthetics ranks amongst the weakest performers. The company's negative book value of -1.47x compares unfavourably to peers such as Adinath Textiles (4.91x) and Sri Nachammai Cotton Mills (1.07x). With a market capitalisation of just ₹14.00 crores, Prag Bosimi ranks second amongst its peer group, though this reflects distressed valuation rather than operational strength.
| Company | P/E (TTM) | P/BV | ROE | Debt/Equity |
|---|---|---|---|---|
| Prag Bosimi Syn. | NA (Loss Making) | -1.47x | 0.0% | -17.25 |
| Adinath Textiles | 296.42x | 4.91x | 0.0% | -0.05 |
| Sri Nacha. Cott. | NA (Loss Making) | 1.07x | 4.30% | 3.94 |
| Alps Industries | NA (Loss Making) | -0.01x | 0.0% | 0.00 |
| Shree Mfg. Co. | NA (Loss Making) | -5.01x | 0.0% | -0.91 |
| Eurotex Industri | NA (Loss Making) | -0.52x | 0.0% | -1.29 |
The peer group analysis reveals a sector in widespread distress, with five of six companies reporting losses and trading at negative or minimal P/E multiples. However, Prag Bosimi's complete absence of revenue generation and negative equity position places it amongst the most severely impaired entities even within this challenged peer set.
Valuation Analysis: Risky Classification Reflects Fundamental Distress
Prag Bosimi Synthetics carries a "RISKY" valuation classification, a designation it has held since April 25, 2023. Traditional valuation metrics offer limited insight given the company's negative earnings and equity. The P/E ratio is classified as "NA (Loss Making)," whilst the price-to-book value of -1.47x reflects the market pricing shares below the negative book value—a paradoxical situation where equity technically has no value.
Enterprise value metrics reveal severe distress: EV/EBITDA of -73.36x, EV/EBIT of -30.21x, and EV/Sales of -174.60x all reflect negative denominators rendering traditional valuation frameworks inapplicable. The EV/Capital Employed ratio of 1.15x suggests the enterprise value approximates capital employed, though with negative returns on that capital, this provides no investment merit.
The stock trades at ₹1.83, down 31.97% from its 52-week high of ₹2.69 but up 29.79% from its 52-week low of ₹1.41. This narrow trading range reflects minimal investor interest and liquidity. With no dividend payments (yield: NA) and a dividend payout ratio of 0.0%, shareholders receive no return on investment beyond potential capital appreciation—a remote prospect given current fundamentals.
Shareholding Pattern: Stable Promoter Holdings Amidst Decline
Promoter holding has remained stable at 48.17% across the last five quarters through March 2026, with no sequential changes. Assam Industrial Development Corporation Ltd. holds the largest promoter stake at 24.71%, followed by Akhilesh Mercantile Pvt Ltd at 8.64%. Critically, there is zero promoter pledging, suggesting promoters retain confidence or lack better exit options.
| Category | Mar'26 | Dec'25 | Sep'25 | Jun'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 48.17% | 48.17% | 48.17% | 48.17% | 0.00% |
| FII | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Mutual Fund | 0.13% | 0.13% | 0.13% | 0.13% | 0.00% |
| Insurance | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Non-Institutional | 51.69% | 51.69% | 51.69% | 51.69% | 0.00% |
Institutional holdings remain negligible at 0.13% from three mutual funds, with zero FII and insurance company participation. The absence of institutional interest reflects the company's distressed status and lack of investment grade characteristics. Non-institutional holdings of 51.69% represent retail investors and other entities, many likely trapped in legacy positions.
Stock Performance: Consistent Underperformance Across All Timeframes
Prag Bosimi Synthetics has delivered negative returns across virtually all measured timeframes, significantly underperforming both the Sensex benchmark and its sector peers. Over the past year, the stock declined 22.13% compared to the Sensex's 8.40% decline, generating negative alpha of 13.73 percentage points. The underperformance intensifies over longer periods: three-year returns of -25.61% versus Sensex gains of 18.98% (alpha: -44.59%), and five-year returns of -20.78% versus Sensex gains of 45.41% (alpha: -66.19%).
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | -2.66% | -0.85% | -1.81% |
| 1 Month | -5.18% | -3.51% | -1.67% |
| 3 Month | +2.81% | -8.01% | +10.82% |
| 6 Month | -8.50% | -12.75% | +4.25% |
| YTD | -10.29% | -12.26% | +1.97% |
| 1 Year | -22.13% | -8.40% | -13.73% |
| 3 Years | -25.61% | +18.98% | -44.59% |
| 5 Years | -20.78% | +45.41% | -66.19% |
The stock's risk-adjusted return over one year stands at -0.39 with volatility of 56.51%, categorising it as "HIGH RISK LOW RETURN." The beta of 1.50 indicates the stock is 50% more volatile than the market, amplifying downside movements during market corrections whilst failing to participate meaningfully in rallies. The Sharpe ratio is negative, confirming investors receive no compensation for the substantial volatility endured.
Against its sector, Prag Bosimi underperformed by 13.84 percentage points over the past year, with the stock declining 22.13% versus the Garments & Apparels sector's 8.29% decline. This consistent underperformance across timeframes and benchmarks reflects fundamental deterioration rather than temporary market sentiment.
Technical Analysis: Mildly Bearish Trend with Limited Support
The stock currently trades in a "MILDLY BEARISH" technical trend, having changed from "Bearish" on April 16, 2026 at ₹1.82. Technical indicators present a mixed picture: MACD shows mildly bullish signals on weekly charts but bearish on monthly, whilst RSI provides no clear directional signal. Bollinger Bands suggest mildly bullish weekly patterns but bearish monthly trends.
The stock trades below all key moving averages: 5-day MA at ₹1.84, 20-day MA at ₹1.86, 50-day MA at ₹1.80, 100-day MA at ₹1.84, and 200-day MA at ₹1.95. This positioning below longer-term moving averages confirms sustained downtrend momentum. Immediate support rests at the 52-week low of ₹1.41, whilst resistance emerges at the 20-day MA around ₹1.86 and more substantially at the 200-day MA of ₹1.95.
Delivery volumes show a one-month increase of 41.59%, though absolute volumes remain minimal. Recent delivery of 8,040 shares on May 27, 2026 represented 86.66% of total volume, suggesting limited speculative interest and predominantly long-term positioning—though whether this reflects conviction or trapped positions remains unclear.
Quality Assessment: Below Average with Fundamental Deficiencies
Prag Bosimi Synthetics carries a "BELOW AVERAGE" quality grade, a classification it has maintained since March 2026, having previously been categorised as "Does Not Qualify" prior to November 2022. The quality assessment reflects severe deficiencies across multiple parameters: negative 100.00% five-year sales growth, weak ROCE of -5.29%, zero ROE, and EBIT-to-interest coverage of 0.0x.
The company does exhibit two positive quality indicators: zero promoter pledging and a net cash position (debt-to-equity of -17.25, though this metric is distorted by negative equity). However, these positives are overwhelmed by fundamental operational failures. Institutional holdings of just 0.13% reflect the absence of sophisticated investor interest, whilst the tax ratio classification as "Tax Ratio is Negative%" confirms sustained losses preclude any tax liability.
Investment Thesis: Distressed Asset with No Clear Recovery Path
The investment thesis for Prag Bosimi Synthetics is fundamentally compromised by structural deficiencies across all four key parameters. The proprietary Mojo score stands at just 17 out of 100, firmly in "STRONG SELL" territory—a rating the stock has maintained since September 2, 2024 at ₹3.13. The current price of ₹1.83 represents a 41.53% decline from that rating point, validating the bearish assessment.
Valuation carries a "RISKY" classification, reflecting negative earnings and equity that render traditional metrics inapplicable. Quality grade registers "BELOW AVERAGE" based on weak long-term financial performance. Financial trend shows "FLAT" for the recent quarter, though this represents marginal improvement from previously "NEGATIVE" classifications. Technical trend remains "MILDLY BEARISH," with the stock trading below all major moving averages.
Key concerns limiting the investment score include: stock trading in bearish technical trend, flat financial performance in the recent quarter, negative book value indicating weak long-term fundamental strength, and consistent underperformance against benchmarks over the past three years. The combination of operational collapse, balance sheet insolvency, and absent revenue generation presents no credible path to recovery without substantial restructuring or external intervention.
Key Strengths & Risk Factors
Key Strengths
Key Concerns
Outlook: What to Watch
Positive Catalysts (Remote Probability)
Red Flags (High Probability)
The Verdict: Distressed Asset with No Recovery Visibility
Score: 17/100
For Fresh Investors: Avoid entirely. The company exhibits characteristics of terminal decline with negative equity, collapsed revenues, and mounting losses. No credible recovery path exists without dramatic restructuring. The "RISKY" valuation classification and "BELOW AVERAGE" quality grade confirm fundamental unsuitability for investment.
For Existing Holders: Exit at any available price to limit further losses. The 111.90% quarter-on-quarter increase in net losses to ₹3.56 crores, combined with negative shareholder equity of ₹3.77 crores, indicates worsening fundamentals. The stock's 22.13% one-year decline and consistent multi-year underperformance validate the exit thesis.
Fair Value Estimate: Not applicable given negative book value and absent earnings. Current price of ₹1.83 likely overvalues the distressed asset. Downside risk to 52-week low of ₹1.41 (23% decline) or lower remains substantial.
Rationale: Prag Bosimi Synthetics combines the worst elements of fundamental distress—negative equity, revenue collapse, mounting losses, and unsustainable debt service—with no visible catalysts for recovery. The Mojo score of 17/100 and "STRONG SELL" rating reflect these structural deficiencies. Investors should recognise this as a distressed situation requiring complete avoidance or immediate exit rather than a temporary setback offering recovery potential.
Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
